Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$6.48 +0.10 (+1.57%)
As of 01:53 PM Eastern

ACB vs. THCX, CRON, GUD, TLRY, FIRE, EPI, WEED, ICC, RIV, and CPH

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Canopy Growth (WEED), ICC Labs (ICC), RIV Capital (RIV), and Cipher Pharmaceuticals (CPH). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs.

Aurora Cannabis (TSE:ACB) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Hydropothecary has lower revenue, but higher earnings than Aurora Cannabis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$195.83M1.81-C$44.16M-C$0.81-8.00
HydropothecaryN/AN/AN/AN/AN/A

Aurora Cannabis received 390 more outperform votes than Hydropothecary when rated by MarketBeat users. However, 72.31% of users gave Hydropothecary an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote.

CompanyUnderperformOutperform
Aurora CannabisOutperform Votes
531
63.14%
Underperform Votes
310
36.86%
HydropothecaryOutperform Votes
141
72.31%
Underperform Votes
54
27.69%

Aurora Cannabis presently has a consensus price target of C$8.75, suggesting a potential upside of 35.03%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, equities analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.33
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-22.55% -8.36% -1.87%
Hydropothecary N/A N/A N/A

In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
Aurora Cannabis Neutral
Hydropothecary Neutral

13.4% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Aurora Cannabis beats Hydropothecary on 6 of the 10 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$354.51MC$2.22BC$5.50BC$5.67B
Dividend YieldN/A2.92%5.11%6.84%
P/E Ratio-8.003.9022.6328.69
Price / Sales1.81511.34397.30609.91
Price / Cash1.2510.2538.1883.20
Price / Book0.596.486.703.71
Net Income-C$44.16MC$20.70BC$3.23BC$301.04M
7 Day Performance-0.92%1.10%1.36%0.15%
1 Month Performance3.35%2.35%3.85%-0.33%
1 Year Performance-36.03%94.43%15.87%13.86%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
1.6981 of 5 stars
C$6.48
+1.6%
C$8.75
+35.0%
-49.6%C$354.51MC$195.83M-8.001,073
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
1.1538 of 5 stars
C$2.38
-2.1%
C$3.54
+48.7%
-36.0%C$628.47MC$76.86M-13.24450
GUD
Knight Therapeutics
1.4084 of 5 stars
C$5.78
+1.6%
C$7.48
+29.3%
+5.4%C$584.65MC$348.70M-19.30725
TLRY
Tilray Brands
N/AC$0.61
-1.6%
N/A-80.1%C$393.06MC$610.34M-1.472,650Positive News
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
WEED
Canopy Growth
1.3499 of 5 stars
C$1.46
-10.4%
C$5.64
+286.2%
-90.7%C$234.87MC$519.68M-0.212,700
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533,684.0095.29N/AGap Up
RIV
RIV Capital
N/AN/AN/AN/AC$213.65MC$11.33M-1.6312
CPH
Cipher Pharmaceuticals
0.6311 of 5 stars
C$11.11
-6.7%
C$14.75
+32.8%
+57.4%C$199.46MC$19.03M12.275

Related Companies and Tools


This page (TSE:ACB) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners